Evaluation of the dopamine β-hydroxylase (DβH) inhibitor nepicastat in participants who meet criteria for cocaine use disorder
Richard De La Garza, Marcy J. Bubar, Crystal L. Carbone, F. Gerard Moeller, Thomas F. Newton, Noelle C. Anastasio, Tod A. Harper, David L. Ware, Michael Fuller, Gaylyn J. Holstein, Jason B. Jayroe, Stephen I. Bandak, Kirsten Z. Reiman, Ann Neale, Lesley B. Pickford, Kathryn A. Cunningham
Abstract